|
rdfs:label
|
"Bortezomib"@de
"Bortezomib"@es
"Bortezomib"@id
"Bortezomib"@it
"Bortezomib"@ro
"Bortezomib"@sh
"Bortezomib"@sr
"Bortezomib"@tr
"Bortezomib"@vi
"bortesomib"@cy
"bortetsomibi"@fi
"bortezomib"@en
"bortezomib"@ca
"bortezomib"@nl
"bortezomib"@nn
"bortezomib"@pl
"bortezomib"@sl
"bortezomib"@uk
"bortezomibas"@lt
"bortezomibe"@pt
"bortézomib"@fr
"бортезомиб"@ru
"بورتزومیب"@azb
"بورتزومیب"@fa
"بورتيزوميب"@ar
"ବୋର୍ଟେଜୋମିବ"@or
"ボルテゾミブ"@ja
"硼替佐米"@zh
"硼替佐米"@zh-cn
"硼替佐米"@zh-hans
"硼替佐米"@zh-hant
"보르테조밉"@ko
|
|
skos:altLabel
|
"N-[(1R)-1-(dihydroxyboryl)-3-methylbutyl]-N-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide"@en
"PS 341"@mul
"PS-341"@mul
"[(1R)-3-methyl-1-({(2S)-3-phenyl-2-[(pyrazin-2-ylcarbonyl)amino]propanoyl}amino)butyl]boronic acid"@en
"peptide boronate"@cy
"peptide boronate"@en
|
|
schema:description
|
"Kompozé chimik"@gcr
"cheemesch Verbindung"@lb
"chemical compound"@en
"chemical compound"@en-ca
"chemical compound"@en-gb
"chemická sloučenina"@cs
"chemická zlúčenina"@sk
"chemiese verbinding"@af
"chemische Verbindung"@de
"chemische Verbindung"@de-ch
"chemische verbinding"@nl
"component quimic"@oc
"composito chimic"@ia
"compositum chemicum"@la
"compost químic"@ca
"composto chimico"@it
"composto químico"@gl
"composto químico"@pt
"composto químico"@pt-br
"composé chimique"@fr
"compuesto quimico"@an
"compuesto químico"@es
"compuestu químicu"@ast
"compus chimic"@ro
"conposto chìmego"@vec
"cumpostu chìmicu"@scn
"cyfansoddyn cemegol"@cy
"gemyske ferbining"@fy
"kediad kimiek"@br
"keemiline ühend"@et
"kemia kombinaĵo"@eo
"kemiala kompozajo"@io
"kemiallinen yhdiste"@fi
"kemisk forbindelse"@da
"kimyasal bileşik"@tr
"kjemisk forbindelse"@nb
"kjemisk sambinding"@nn
"komponim kimik"@sq
"konposatu kimiko"@eu
"senyawa kimia"@id
"związek chemiczny"@pl
"ķīmisks savienojums"@lv
"χημική ένωση"@el
"хемиско соединение"@mk
"химическое соединение"@ru
"химично съединение"@bg
"хімічна сполука"@uk
"хімічнае злучэнне"@be
"хімічнае злучэньне"@be-tarask
"քիմիական միացություն"@hy
"תרכובת"@he
"مركب كيميائي"@ar
"کیٖمیٲیی مُرَکَب"@ks
"রাসায়নিক যৌগ"@bn
"ବୋର୍ଟେଜୋମିବ ଏକ କର୍କଟ ବିରୋଧୀ ଔଷଧ ଯାହା ମଲ୍ଟିପ୍ଲ ମାୟେଲୋମା ଏବଂ ମାଣ୍ଟଲ ଜୀବକୋଷ ଲିମ୍ଫୋମା ରୋଗମାନଙ୍କ ଚିକିତ୍ସା ପାଇଁ ବ୍ୟବହାର କରାଯାଏ ।"@or
"രാസസംയുക്തം"@ml
"化合物"@yue
"化合物"@zh
"化合物"@zh-cn
"化合物"@zh-hans
"化合物"@zh-hant
"化合物"@zh-hk
"化合物"@zh-sg
"化合物"@zh-tw
"化合物"@zh-mo
|
|
schema:dateModified
|
"2026-09-19T15:37:56+00:00"^^xsd:dateTime
|
|
schema:version
|
2547760765
|
|
wikibase:identifiers
|
65
|
|
wikibase:sitelinks
|
26
|
|
wikibase:statements
|
100
|
|
p:P10245
|
wd:statement/Q419319-d1292d26-420c-f138-624a-2d3cde1a4ead
|
|
p:P10283
|
wd:statement/Q419319-D38AFEEB-0D7A-4154-92AA-B9059DD4BA5A
|
|
p:P11089
|
wd:statement/Q419319-F659006E-D350-46CE-A995-3EB4D01FBEDC
|
|
p:P11143
|
wd:statement/Q419319-8859E683-1B74-4B15-922B-0EC6B00A9829
|
|
p:P11198
|
wd:statement/Q419319-655D7395-99E6-45CF-AA35-69489ECF0993
|
|
p:P11199
|
wd:statement/Q419319-DC26CD57-6E16-4410-9E69-2E8A35CC4FCB
|
|
p:P117
|
wd:statement/Q419319-FBFC1526-8593-48DD-8792-5BFC0FF7C4A6
|
|
p:P129
|
wd:statement/Q419319-B9071665-0B14-46BA-9E29-4FB2D0047B70
|
|
p:P1579
|
wd:statement/Q419319-9FAB8F62-595C-4771-8EAF-CC102CA7BE6E
|
|
p:P176
|
wd:statement/Q419319-A0D13CB5-9E01-4B09-B403-047B504CC6BD
|
|
p:P2017
|
wd:statement/Q419319-5DD566D7-9ACE-46A7-B771-E2E2615804BD
|
|
p:P2057
|
wd:statement/Q419319-70520EEE-3BC2-4AC2-A4D6-C1DC31E0AF83
|
|
p:P2062
|
wd:statement/Q419319-CACBCFE4-D61B-45AB-BFE7-8B7940F11686
|
|
p:P2067
|
wd:statement/Q419319-1F8F4B82-45C8-4FE6-A8DE-D415CB904A06
|
|
p:P2115
|
wd:statement/Q419319-EC48353E-2D8D-4DE7-9071-0BDFF59B27AD
|
|
p:P2175
|
wd:statement/Q419319-002034BE-2A69-41D4-B3DF-4E5E8176491E
|
|
wd:statement/Q419319-0686F2BB-1D73-4AD1-9C8D-D719B8401A18
|
|
wd:statement/Q419319-07419024-79B4-4926-A367-DBD39C96DE15
|
|
wd:statement/Q419319-165B9DE0-7565-4FD7-AAA2-58C40479631C
|
|
wd:statement/Q419319-42F8C68E-5B56-4DCA-BAD2-367B8FC0B68B
|
|
wd:statement/Q419319-52D2229A-2F4D-46D0-98D8-9301D3348BE1
|
|
wd:statement/Q419319-915EB824-54DB-4099-BD0E-303ED1CCC6EE
|
|
wd:statement/Q419319-9F4E6AE4-2C72-43D8-8795-767CB2420AEA
|
|
wd:statement/Q419319-A5F07732-5EF0-493F-BE37-8DD092D20BA3
|
|
wd:statement/Q419319-D0619F6B-3965-490E-A09B-F718A26C3B0D
|
|
wd:statement/Q419319-D2310C17-B8B3-4AB1-BBB0-D879427C2662
|
|
p:P2275
|
wd:statement/Q419319-BB55F639-759E-4195-B933-53115BBF41D7
|
|
p:P231
|
wd:statement/Q419319-4AA6B12B-BAAE-4DD2-9DD4-1AD776C3DCA0
|
|
p:P232
|
wd:statement/Q419319-933bf401-42d0-9fad-3238-6067a7378f7e
|
|
p:P233
|
wd:statement/Q419319-741B5375-A77B-4D53-85EC-0F4018680175
|
|
p:P234
|
wd:statement/Q419319-CCC88984-3DB5-4E31-9FD4-C78EB7B6A272
|
|
p:P235
|
wd:statement/Q419319-E4B37BF9-EC9F-41F7-BADC-2F7750D7894C
|
|
p:P2566
|
wd:statement/Q419319-13572468-2468-1357-eca9-bdf024681357
|
|
p:P267
|
wd:statement/Q419319-CC86EAF0-F9D0-47FC-B24F-58FA9053D09B
|
|
p:P274
|
wd:statement/Q419319-33BC2376-D844-4187-9C95-CB159FB754F5
|
|
p:P279
|
wd:statement/Q419319-660178CC-6A4F-4CFE-B600-3B60CC415B52
|
|
p:P2840
|
wd:statement/Q419319-78C65C9F-E649-4A66-9C8F-771C78EC889C
|
|
p:P2868
|
wd:statement/Q419319-E18D2703-9557-44B3-AC16-ECC31173CA0A
|
|
p:P2877
|
wd:statement/Q419319-1D2FAD00-5DF3-4351-9432-F08238E8B459
|
|
wd:statement/Q419319-3647C761-A085-4ACD-A200-2EC23D60CD2B
|
|
p:P2892
|
wd:statement/Q419319-80C9078B-6459-44D5-95BA-84CBFEF079F5
|
|
p:P31
|
wd:statement/Q419319-2CD6CD68-5B74-4DE7-9921-03CCACB84E28
|
|
p:P3117
|
wd:statement/Q419319-F10925ED-6CE7-45B6-AC81-4E6E8A357A70
|
|
p:P3345
|
wd:statement/Q419319-7BF5CF25-A85D-47A7-8710-8453B4B32824
|
|
p:P3364
|
wd:statement/Q419319-2E2AA3B0-F82C-458D-9B00-982F2B75998E
|
|
wd:statement/Q419319-4D81FDCC-B89F-4C36-85BC-1B0C118B472E
|
|
p:P3489
|
wd:statement/Q419319-B2B197A1-48A7-46A9-8F3A-C987A64EFD9E
|
|
wd:statement/Q419319-E717C6E3-0A1E-4A72-87B5-8D6507102047
|
|
p:P3636
|
wd:statement/Q419319-665B9528-0FCF-4F5F-9317-236966C67AD5
|
|
p:P366
|
wd:statement/Q419319-46F392E2-7C45-4ECC-ABC9-FCA1E1DC61A9
|
|
p:P373
|
wd:statement/Q419319-C5008791-AE9F-4FB3-B01F-7C89FE2E2D84
|
|
p:P3780
|
wd:statement/Q419319-1952CF34-378E-4438-A2CC-464AB2062701
|
|
wd:statement/Q419319-20AC9BCA-6069-42A7-A718-1862E26D88D4
|
|
wd:statement/Q419319-B485737C-9FE5-4FE7-AF24-511F1CF64E68
|
|
wd:statement/Q419319-CD9FB1D7-7815-4294-9F50-970DA5EA7B23
|
|
p:P4527
|
wd:statement/Q419319-08139001-D37C-431D-A17D-E05066FC343F
|
|
p:P486
|
wd:statement/Q419319-FCEBADDB-A09C-436E-B727-A5335D3FE815
|
|
p:P4964
|
wd:statement/Q419319-1651F841-22BC-4A71-8941-7558431D3A95
|
|
p:P592
|
wd:statement/Q419319-4B7D24A8-0E4E-4737-98D0-A7F04E8F8DE9
|
|
p:P595
|
wd:statement/Q419319-2E281FD1-A916-4450-9F3D-FF1F7A545AE9
|
|
p:P6366
|
wd:statement/Q419319-F6F9BE2D-7332-40B7-9ED9-AE9AA8E03347
|
|
p:P638
|
wd:statement/Q419319-0330B300-5C93-4564-97E2-D4F033639FE6
|
|
wd:statement/Q419319-0529B77D-6B64-4F1B-85E7-BE72E6A51E13
|
|
wd:statement/Q419319-0D23B86C-6C8F-4118-A286-2C7D44EF3D9F
|
|
wd:statement/Q419319-2C59B9E1-5278-406C-85C9-582F9C258E0A
|
|
wd:statement/Q419319-3FF66AE1-A443-48DF-B63A-6C75501E4CD4
|
|
wd:statement/Q419319-44869BE6-28EA-40F1-BD1B-B91D84BA03CD
|
|
wd:statement/Q419319-4809FE14-B478-4061-AFD6-D991E5C5F0E4
|
|
wd:statement/Q419319-50693FA3-0FCD-4840-993B-2862C5DCCDBE
|
|
wd:statement/Q419319-513FE660-40D3-4907-BDE7-F3495C80F9FC
|
|
wd:statement/Q419319-695130F3-7A68-403B-9946-AEB25DAAB159
|
|
wd:statement/Q419319-6E4D9F58-3B66-44EB-AAC4-31E90564D8A3
|
|
wd:statement/Q419319-73D77882-08BC-485A-9766-91849478E3A2
|
|
wd:statement/Q419319-7E9C67D2-F18F-4A78-A94A-9E62B13957A1
|
|
wd:statement/Q419319-97CE2787-3CF3-408F-87DA-93D69FA6D441
|
|
wd:statement/Q419319-99228FA1-CB9D-401A-AD7D-ED57677D5CA1
|
|
wd:statement/Q419319-9B879C32-F5A9-46E4-BBEA-1E945CA188CB
|
|
wd:statement/Q419319-B76C7494-3FAA-4805-BEC1-F5C3846169FF
|
|
wd:statement/Q419319-D2B96AFD-89A8-4636-9D2B-789DC8DD7D4F
|
|
wd:statement/Q419319-F92C9FD1-753F-4880-93FD-7F64914D606E
|
|
wd:statement/Q419319-FB373556-C3F3-4D21-B064-F9CB17085038
|
|
p:P646
|
wd:statement/Q419319-A93AA7EA-52CB-4D6D-BE36-B29EA535C8AE
|
|
p:P652
|
wd:statement/Q419319-B4041A28-0B54-41FB-B574-798ADFFBD7E6
|
|
p:P661
|
wd:statement/Q419319-12E824A3-1A1A-4B1D-BB16-BFBAF8A6DD1F
|
|
p:P662
|
wd:statement/Q419319-D7D7358C-A3DB-43C1-BE54-7EC8CAFF1B88
|
|
p:P665
|
wd:statement/Q419319-D0626D2E-A59C-4401-B6E1-8186CAA974D0
|
|
p:P6694
|
wd:statement/Q419319-C2121DC0-801D-42F8-B0EE-522433ECD54C
|
|
p:P672
|
wd:statement/Q419319-002b6b45-448b-9018-33f9-59b78724532e
|
|
wd:statement/Q419319-61c88542-414c-d99f-5128-51af97ef24d9
|
|
wd:statement/Q419319-b117e461-4357-4a5f-e0ef-5648aa8f502b
|
|
wd:statement/Q419319-e24e6157-4e06-d6ce-7b3e-7d9e1f40fac6
|
|
p:P683
|
wd:statement/Q419319-97A35096-1822-4E56-8FA9-A1CD1374F741
|
|
p:P715
|
wd:statement/Q419319-FC8B700A-DFDD-4F28-B998-47F8765B654C
|
|
p:P769
|
wd:statement/Q419319-1DDCB475-A5DA-46FA-8017-B367277A8BF5
|
|
wd:statement/Q419319-E6BA29A2-DDD7-41CB-B288-E3E8EA2C8DA7
|
|
p:P7830
|
wd:statement/Q419319-EA038572-544C-407A-90F0-CD52646CE31A
|
|
p:P8026
|
wd:statement/Q419319-5205A3EF-1731-43E9-B75B-28BFC14F0D15
|
|
p:P8494
|
wd:statement/Q419319-F979E24A-E90E-4309-AE8B-82C4E01695AA
|
|
p:P9272
|
wd:statement/Q419319-47E7E7B7-ADE1-4405-ABB2-8C455D9124A9
|
|
p:P9635
|
wd:statement/Q419319-A7C54345-2262-4AFC-84F0-0767E8AF1C2B
|
|
p:direct-normalized/P2115
|
<http://purl.bioontology.org/ontology/NDFRT/N0000148811>
|
|
p:direct-normalized/P4527
|
<http://data.parliament.uk/terms/422025>
|
|
p:direct-normalized/P486
|
<http://id.nlm.nih.gov/mesh/D000069286>
|
|
p:direct-normalized/P592
|
<http://rdf.ebi.ac.uk/resource/chembl/molecule/CHEMBL325041>
|
|
p:direct-normalized/P6366
|
<https://makg.org/entity/2777478702>
|
|
p:direct-normalized/P638
|
<https://rdf.wwpdb.org/pdb/2F16>
|
|
<https://rdf.wwpdb.org/pdb/3MG0>
|
|
<https://rdf.wwpdb.org/pdb/4FWD>
|
|
<https://rdf.wwpdb.org/pdb/4QVL>
|
|
<https://rdf.wwpdb.org/pdb/4QVM>
|
|
<https://rdf.wwpdb.org/pdb/4QVN>
|
|
<https://rdf.wwpdb.org/pdb/4QVP>
|
|
<https://rdf.wwpdb.org/pdb/4QVQ>
|
|
<https://rdf.wwpdb.org/pdb/4QVV>
|
|
<https://rdf.wwpdb.org/pdb/4QVW>
|
|
<https://rdf.wwpdb.org/pdb/4QVY>
|
|
<https://rdf.wwpdb.org/pdb/4QW0>
|
|
<https://rdf.wwpdb.org/pdb/4QW1>
|
|
<https://rdf.wwpdb.org/pdb/4QW3>
|
|
<https://rdf.wwpdb.org/pdb/4QWU>
|
|
<https://rdf.wwpdb.org/pdb/4YPM>
|
|
<https://rdf.wwpdb.org/pdb/5BXN>
|
|
<https://rdf.wwpdb.org/pdb/5CZ7>
|
|
<https://rdf.wwpdb.org/pdb/5D0X>
|
|
<https://rdf.wwpdb.org/pdb/5LF3>
|
|
p:direct-normalized/P661
|
<http://rdf.chemspider.com/343402>
|
|
p:direct-normalized/P662
|
<http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID387447>
|
|
p:direct-normalized/P665
|
<http://www.kegg.jp/entry/D03150>
|
|
p:direct-normalized/P6694
|
<http://id.nlm.nih.gov/mesh/M0350110>
|
|
p:direct-normalized/P672
|
<http://id.nlm.nih.gov/mesh/D01.029.260.110.500>
|
|
<http://id.nlm.nih.gov/mesh/D01.132.285.500>
|
|
<http://id.nlm.nih.gov/mesh/D02.203.200.500>
|
|
<http://id.nlm.nih.gov/mesh/D03.383.679.450>
|
|
p:direct-normalized/P683
|
<http://purl.obolibrary.org/obo/CHEBI_52717>
|
|
wdt:P10245
|
"a607007"
|
|
wdt:P10283
|
"C2777478702"
|
|
wdt:P11089
|
"503765"
|
|
wdt:P11143
|
"Bortezomib"
|
|
wdt:P11198
|
"391"
|
|
wdt:P11199
|
"PD003632"
|
|
wdt:P117
|
<http://commons.wikimedia.org/wiki/Special:FilePath/Bortezomib.svg>
|
|
wdt:P129
|
Proteasome 20S subunit beta 5
|
|
wdt:P1579
|
"8723817"
|
|
wdt:P176
|
Pfizer
|
|
wdt:P2017
|
"B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O"
|
|
wdt:P2057
|
"HMDB0014334"
|
|
wdt:P2062
|
"7666"
|
|
wdt:P2067
|
384.197^^xsd:decimal
|
|
wdt:P2115
|
"N0000148811"
|
|
wdt:P2175
|
non-Hodgkin lymphoma
|
|
Waldenström macroglobulinemia
|
|
plasmacytoma
|
|
diffuse large B-cell lymphoma
|
|
acute myeloid leukemia
|
|
mantle cell lymphoma
|
|
multiple myeloma
|
|
B-cell lymphoma
|
|
plasma cell leukemia
|
|
precursor T-cell lymphoblastic leukemia
|
|
amyloidosis
|
|
wdt:P2275
|
"bortezomib"@en
|
|
wdt:P231
|
"179324-69-7"
|
|
wdt:P232
|
"605-854-3"
|
|
wdt:P233
|
"B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O"
|
|
wdt:P234
|
"InChI=1S/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1-2H3,(H,23,26)(H,24,25)/t15-,17-/m0/s1"
|
|
wdt:P235
|
"GXJABQQUPOEUTA-RDJZCZTQSA-N"
|
|
wdt:P2566
|
"100.125.601"
|
|
wdt:P267
|
"L01XX32"
|
|
wdt:P274
|
"C₁₉H₂₅BN₄O₄"
|
|
wdt:P279
|
[3-methyl-1-[[1-oxo-2-[[oxo(2-pyrazinyl)methyl]amino]-3-phenylpropyl]amino]butyl]boronic acid
|
|
wdt:P2840
|
"681239"
|
|
wdt:P2868
|
antineoplastic
|
|
wdt:P2877
|
"192129"
|
|
"29377226"
|
|
wdt:P2892
|
"C1176309"
|
|
wdt:P31
|
type of chemical entity
|
|
wdt:P3117
|
"DTXSID3040980"
|
|
wdt:P3345
|
"358258"
|
|
wdt:P3364
|
N-[(1S)-1-Borono-3-methylbutyl]-Nalpha-(pyrazine-2-carbonyl)-L-phenylalaninamide
|
|
N-[(1R)-1-Borono-3-methylbutyl]-Nalpha-(pyrazine-2-carbonyl)-D-phenylalaninamide
|
|
wdt:P3489
|
US pregnancy category D
|
|
Australian pregnancy category C
|
|
wdt:P3636
|
"BO2"
|
|
wdt:P366
|
medication
|
|
wdt:P373
|
"Bortezomib"
|
|
wdt:P3780
|
Bortezomib Accord
|
|
Bortezomib Hospira
|
|
Bortezomib Sun
|
|
Velcade
|
|
wdt:P4527
|
"422025"
|
|
wdt:P486
|
"D000069286"
|
|
wdt:P4964
|
"splash10-016r-1397000000-e168634cfe7e1453d742"
|
|
wdt:P592
|
"CHEMBL325041"
|
|
wdt:P595
|
"6391"
|
|
wdt:P6366
|
"2777478702"
|
|
wdt:P638
|
"2F16"
|
|
"3MG0"
|
|
"4FWD"
|
|
"4QVL"
|
|
"4QVM"
|
|
"4QVN"
|
|
"4QVP"
|
|
"4QVQ"
|
|
"4QVV"
|
|
"4QVW"
|
|
"4QVY"
|
|
"4QW0"
|
|
"4QW1"
|
|
"4QW3"
|
|
"4QWU"
|
|
"4YPM"
|
|
"5BXN"
|
|
"5CZ7"
|
|
"5D0X"
|
|
"5LF3"
|
|
wdt:P646
|
"/m/06fq0v"
|
|
wdt:P652
|
"69G8BD63PP"
|
|
wdt:P661
|
"343402"
|
|
wdt:P662
|
"387447"
|
|
wdt:P665
|
"D03150"
|
|
wdt:P6694
|
"M0350110"
|
|
wdt:P672
|
"D01.029.260.110.500"
|
|
"D01.132.285.500"
|
|
"D02.203.200.500"
|
|
"D03.383.679.450"
|
|
wdt:P683
|
"52717"
|
|
wdt:P715
|
"DB00188"
|
|
wdt:P769
|
phenytoin
|
|
fosphenytoin
|
|
wdt:P7830
|
"Bortezomib"
|
|
wdt:P8026
|
LiverTox toxicity likelihood category C
|
|
wdt:P8494
|
"DTXCID1020980"
|
|
wdt:P9272
|
"55856"
|
|
wdt:P9635
|
"407"
|